Page last updated: 2024-11-07

8-azidoadenosine diphosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

8-Azidoadenosine diphosphate (8-N3ADP) is a synthetic analog of adenosine diphosphate (ADP). It is a photoaffinity label that is used to study the binding sites of proteins that interact with ADP. The azido group (-N3) in 8-N3ADP is a photoreactive group that can be activated by ultraviolet light to form a highly reactive nitrene. The nitrene can then react with nearby amino acid residues in the protein, forming a covalent bond. This covalent bond can then be used to identify the binding site of the protein. 8-N3ADP is important for studying the mechanism of action of enzymes that utilize ADP, such as kinases and phosphatases. It is also used to study the structure and function of other proteins that bind to ADP, such as ion channels and receptors. 8-N3ADP is studied because it provides a powerful tool for investigating the binding sites of proteins that interact with ADP. By using 8-N3ADP, researchers can identify the amino acid residues that are involved in the binding process. This information can then be used to develop new drugs that target these binding sites.'

Cross-References

ID SourceID
PubMed CID121934
MeSH IDM0076812

Synonyms (11)

Synonym
59432-65-4
8-azido-adp
8-azidoadenosine 5'-(trihydrogen diphosphate)
8-azidoadenosine diphosphate
unii-gsn94of83m
gsn94of83m ,
8-azidoadenosine 5'-diphosphate
8-azidoadenosine-5'-o-diphosphate(8-n3-adp)
DTXSID70974840
8-azido-9-{5-o-[hydroxy(phosphonooxy)phosphoryl]pentofuranosyl}-9h-purin-6-amine
Q27279260
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (30.00)18.7374
1990's8 (26.67)18.2507
2000's13 (43.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (96.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]